Senseonics Holdings, Inc.
Senseonics Holdings, Inc.
Your view on SENS
Overview
What the company does, where it operates, and who runs it.
About Senseonics Holdings, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Timothy T. Goodnow
- Headquarters
- 20451 Seneca Meadows Parkway, Germantown, MD, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Timothy T. Goodnow
- Headquarters
- 20451 Seneca Meadows Parkway, Germantown, MD, US
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa.
The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months.
It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Senseonics Holdings, Inc., and the rating behind it. SENS last traded at $8.71; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Senseonics Holdings, Inc.. Starting points for Senseonics Holdings, Inc.: EPS -$1.89, beta 0.97 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Senseonics Holdings, Inc.. Senseonics Holdings, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Senseonics Holdings, Inc.. Trailing twelve-month EPS for Senseonics Holdings, Inc. stands at -$1.89. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Senseonics Holdings, Inc.. Senseonics Holdings, Inc. has reported as a listed company since 2015. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Senseonics Holdings, Inc. valued side by side against its closest peers. Senseonics Holdings, Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Senseonics Holdings, Inc., and how their positions are changing. At a $364.0M market value, institutional positions materially move Senseonics Holdings, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Senseonics Holdings, Inc. executives and directors. Shares of Senseonics Holdings, Inc. have traded between $5.00 and $28.00 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Senseonics Holdings, Inc.. Senseonics Holdings, Inc. is a $364.0M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Senseonics Holdings, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Senseonics Holdings, Inc.. Coverage tracks Senseonics Holdings, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.